Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomized Trial of Three Antibiotic Regimens to Eradicate Helicobacter Pylori

NCT01061437 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.

NCT NCT01061437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01061437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomized Trial of Three Antibiotic Regimens to Eradicate Helicobacter Pylori
Lead sponsor
SWOG Cancer Research Network
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2009
Completion date
July 31, 2011
Enrollment
1,859 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter pylori infection